Drug Development

CERSI Conference Spotlights New Applications for Top-Down Mass Spectrometry

June 30, 2014

Researchers from academia, government, and industry examine benefits and new methods associated with emerging technology.

SOP Hosts Third International Conference on Microneedles

June 11, 2014

Event brings together researchers from academia, industry, and government to network and share the latest developments in microneedle technology and applications.

CERSI Conference Spotlights Need for Mass Spectrometry in Drug Development

April 16, 2014

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

SOP Awarded Federal Contract to Study Abuse Deterrence of Opioid Drugs

November 6, 2013

Research seeks to improve formulation and manufacturing of opioid medications; deter individuals from abusing powerful pain relievers.

Ellis S. Grollman Lecture Brings Leaders in Pharmaceutical Sciences to SOP

November 15, 2012

Leslie Benet, PhD, professor and former chair of the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF), delivers keynote address.

Industry, FDA Call for Strides in Regulatory Science at UM Center Launch

September 14, 2012

Center of Excellence in Regulatory Science and Innovation taps researchers at Baltimore and College Park campuses, Food and Drug Administration, and industry to make a difference.